Abstract

Case Report

McArdle’s Disease (Glycogen Storage Disease type V): A Clinical Case

Cameselle-Teijeiro JF*, Calheiros-Cruz T, Caamaño-Vara MP, Villar-Fernández B, Ruibal-Azevedo J, Cameselle-Cortizo L, Cameselle-Arias M, Charro Gamallo ME, Turienzo-Pacho F and Yera Acosta A

Published: 31 December, 2018 | Volume 2 - Issue 1 | Pages: 019-023

McArdle’s Disease, or Glycogen Storage Disease Type V, is the result of a deficiency in one of the enzymes responsible for the metabolism of glycogen in the body. Individuals with this disease, lack or produce very small concentrations of the myophosphorylase or glycogen phosphorylase enzyme.

McArdle’s disease is a metabolic and recessive genetic disease caused by a mutation on the PYGM gene located on chromosome 11q13. This gene is responsible for the synthesis of the myophosphorylase (or glycogen phosphorylase) enzyme. It is the most common form of muscular glycogenesis. We present here the clinical case of a 35 years old woman diagnosed with McArdle’s disease at the age of 21 after a visit to a Neurologist. It was confirmed that the patient had shown symptoms of this disease at least 10 years before definitive diagnosis: intolerance to exercise, asthenia and muscular weakness. In this report we describe the different signs and symptoms of the disease, as well as the tests performed to confirm the diagnosis by muscle biopsy and genetic analysis. McArdle’s disease is classified as a rare disease and often its diagnosis is delayed due to a lack of knowledge about its symptoms and signs. Our intention is to make, with the description of our clinical case, the information about this disease more available to physicians to prevent future misinterpretations and delayed diagnosis. A medical documentary we have created on “McArdle’s Disease” can be seen in YouTube using the following links: https://youtu.be/HAhoZ7jxz7Q (English version) and https://youtu.be/uZopzSHOl20 (Spanish version).

Read Full Article HTML DOI: 10.29328/journal.acr.1001010 Cite this Article Read Full Article PDF

Keywords:

McArdle’s disease (Glycogen Storage Disease type V); Rare disease; Myophosphorylase emzyme; Glycogen phosphorylase enzyme; Muscle glycogenosis; CPK; GSDV

References

  1. Taylor RL, Davis M, Turner E, Brull A, Pinos T, et al. Clinical utility gene card for McArdle disease. European Journal of Human Genetics. 2018; 26: 758–764. Ref.: https://goo.gl/nXGVCj
  2. Nogales-Gadea G, Brull A, Santalla A, Andreu AL, Arenas J, et al. McArdle disease: update of reported mutations and polymorphisms in the PYGM gene. Hum Mutat. 2015; 36: 669–678. Ref.: https://goo.gl/yttcfi
  3. Vieitez I, Teijeira S, Fernandez JM, San Millan B, Miranda S, et al. Molecular and clinical study of McArdle’s disease in a cohort of 123 European patients. Identification of 20 novel mutations. Neuromuscul Disord. 2011; 21: 817–823. Ref.: https://goo.gl/J67zuz
  4. Nogales-Gadea G, Rubio JC, Fernandez-Cadenas I, Garcia-Consuegra I, Lucia A, et al. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay. Hum Mutat. 2008; 29: 277–283. Ref.: https://goo.gl/aSPq79
  5. Park HJ, Shin HY, Cho YN, Kim SM, Choi YC. The significance of clinical and laboratory features in the diagnosis of glycogen storage disease type v: a case report. J Korean Med Sci. 2014; 29: 1021-1024. Ref.: https://goo.gl/aVqDtU
  6. Martín MA, Lucía A, Arenas J, Andreu AL. Glycogen Storage Disease Type V. Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.2006 Apr 19 [Updated 2014 Jun 26]. Ref.: https://goo.gl/Ybqc9r
  7. Quinlivan R, Martinuzzi A, Schoser B. Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V). Cochrane Database Syst Rev. 2014: CD003458. Ref.: https://goo.gl/ZHECTs
  8. Keel BR, Brit M. McArdle's disease: a clinical review and case report. Tenn Med. 2013; 106: 33-37. Ref.: https://goo.gl/5xAtJi
  9. Porcelli S, Marzorati M, Belletti M, Bellistri G, Morandi L, et al. The "second wind" in McArdle's disease patients during a second bout of constant work rate submaximal exercise. J Appl Physiol (1985). 2014; 116: 1230-1237. Ref.: https://goo.gl/foShQf
  10. Kouwenberg CV, Voermans NC, Quinlivan R, van den Engel-Hoek L. Mastication and Oral Motor Function in McArdle Disease: Patient Reported Complaints. J Neuromuscul Dis 2018; 5: 353-357. Ref.: https://goo.gl/pfQPzX
  11. Scalco RS, Morrow JM, Booth S, Chatfield S, Godfrey R, et al. Misdiagnosis is an important factor for diagnostic delay in McArdle disease. Neuromuscul Disord. 2017; 27: 852-855. Ref.: https://goo.gl/iDMQbu
  12. Brady S, Godfrey R, Scalco RS, Quinlivan RM. Emotionally-intense situations can result in rhabdomyolysis in McArdle disease. BMJ Case Rep. 2014; 2014. pii: bcr2013203272. Ref.: https://goo.gl/3exr7F
  13. Kazemi-Esfarjani P, Skomorowska E, Jensen TD, Haller RG, Vissing J. A nonischemic forearm exercise test for McArdle disease. Ann Neurol 2002; 52: 153-159. Ref.: https://goo.gl/qtv3hk
  14. Triplet JJ, Goss DA, Taylor B. Spontaneous Compartment Syndrome in a Patient with McArdle Disease: A Case Report and Review of the Literature. JBJS Case Connect. 2017; 7: e49. Ref.: https://goo.gl/N8UUYe
  15. Rodríguez-Gómez I, Santalla A, Díez-Bermejo J, Munguía-Izquierdo D, Alegre LM, et al. A New Condition in McArdle Disease: Poor Bone Health-Benefits of an Active Lifestyle. Med Sci Sports Exerc. 2018; 50: 3-10. Ref.: https://goo.gl/Gz9mDB

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

  • McArdle’s Disease (Glycogen Storage Disease type V): A Clinical Case
    Cameselle-Teijeiro JF*, Calheiros-Cruz T, Caamaño-Vara MP, Villar-Fernández B, Ruibal-Azevedo J, Cameselle-Cortizo L, Cameselle-Arias M, Charro Gamallo ME, Turienzo-Pacho F and Yera Acosta A Cameselle-Teijeiro JF*,Calheiros-Cruz T,Caamaño-Vara MP,Villar-Fernández B,Ruibal-Azevedo J,Cameselle-Cortizo L,Cameselle-Arias M,Charro Gamallo ME,Turienzo-Pacho F,Yera Acosta A. McArdle’s Disease (Glycogen Storage Disease type V): A Clinical Case. . 2018 doi: 10.29328/journal.acr.1001010; 2: 019-023
  • Primary follicular lymphoma arising from the ascendant colon: A case report
    Sofiene Gabsi, Atallah Aziz, Mohamed Hajri, Zied Hadrich*, Sahir Omrani, Rached Bayar and Hafedh Mestiri Sofiene Gabsi,Atallah Aziz,Mohamed Hajri,Zied Hadrich*,Sahir Omrani,Rached Bayar,Hafedh Mestiri. Primary follicular lymphoma arising from the ascendant colon: A case report. . 2023 doi: 10.29328/journal.acr.1001065; 7: 003-005

Recently Viewed

Read More

Most Viewed

Read More